Topical peptide serums: Do they actually reverse skin aging?

What did @natalieyaelwyse actually say?

Honestly? Not much. The transcript from this 278K-view video is entirely song lyrics, "Show me that no, we know my name, Don't mean nobody, just need your body." There are no spoken skincare claims captured in the transcript at all. The video's actual content, based on the caption, is a ranking of five peptide skincare products: Naturium peptide moisturizer, Allies of Skin multi peptide lifting serum, The Ordinary face peptide serum, OneSkin eye serum, and Medik8 Liquid Peptide Advanced.

Because the transcript contains zero factual claims about peptides, ingredients, or skin biology, this fact-check pivots to evaluate the implicit claims embedded in the product category itself and what consumers watching a peptide ranking video are likely to walk away believing.

Does the science back up topical peptide claims?

Short answer: partially, with a lot of caveats most skincare creators skip over. Topical peptides are not the same as injected therapeutic peptides, and the evidence gap between those two categories is enormous.

Signal peptides like Matrixyl (palmitoyl pentapeptide-4) have actual randomized trial data. Gorouhi and Maibach (2009, International Journal of Cosmetic Science) reviewed peptide evidence and found palmitoyl pentapeptide-4 reduced wrinkle depth in controlled studies, though effect sizes were modest. GHK-Cu, a copper peptide appearing in several products including some OneSkin formulations, has demonstrated fibroblast stimulation in cell culture studies (Pickart et al., 2012, Journal of Aging Research), but in-vitro results do not automatically translate to measurable skin change when the peptide is sitting in a moisturizer on your face.

The penetration problem is real. Peptides are large, hydrophilic molecules. Without specific delivery systems, most do not breach the stratum corneum at concentrations that would matter. A product listing "peptides" in its ingredient deck tells you almost nothing about bioavailability.

What did the video get wrong or right?

Without spoken claims, there is nothing to directly fact-check as wrong. But the framing of a peptide "ranking" carries implicit assumptions worth pushing back on. Ranking topical peptide products as if potency can be assessed by feel, texture, or visible results over days of use is not how peptide efficacy works.

OneSkin does fund its own research and has published on OS-01, a peptide targeting senescent cells (Zonari et al., 2023, npj Aging). That is more scientific transparency than most skincare brands offer. Credit where it is due. But peer-reviewed funded by the company selling the product is a different standard than independent replication.

The Ordinary's peptide serum uses Argireline (acetyl hexapeptide-3), which mimics botulinum toxin mechanisms in theory. The evidence for topical Argireline is thin. Blanes-Mira et al. (2002, International Journal of Cosmetic Science) showed effects in a small industry-funded trial. Independent confirmation is lacking.

What should you actually know?

Topical peptides are not the same category as therapeutic injectable peptides like BPC-157, TB-500, or GHK-Cu used in clinical or compounded peptide therapy. Conflating them, which TikTok's algorithm happily does by grouping this content under "peptide therapy," creates real consumer confusion.

If you are interested in peptides for skin aging, here is what the evidence actually supports: copper peptides and Matrixyl variants have the strongest topical data, though still modest. Delivery vehicle matters as much as the peptide itself. No topical peptide serum has demonstrated the tissue-repair effects seen in systemic or injectable GHK-Cu research.

Product rankings based on sensory experience, application feel, or short-term use are essentially meaningless for evaluating peptide bioactivity. Collagen remodeling takes 12 weeks minimum to show measurable change. Anyone ranking five peptide serums on TikTok is ranking packaging and texture perception, not peptide efficacy.

• Look for independent, peer-reviewed data, not brand-sponsored white papers.
• Check whether the peptide has a delivery system designed to improve skin penetration.
• Concentration matters. Products rarely disclose it, which is itself a red flag.
• Consult a dermatologist or telehealth provider before layering multiple peptide actives, particularly if you are also using retinoids or exfoliants.